Roughly 550,000 people enrolled in Humana Medicare Advantage plans face the loss of their current coverage after the insurer announced it will pull out of counties it considers unprofitable for the 2026 plan year. The decision forces affected members to find replacement plans during the fall open enrollment period or risk gaps in care. Humana’s retreat stands in tension with the federal government’s own projection that Medicare Advantage will hold steady next year, raising pointed questions about who absorbs the cost when a major carrier walks away.
Why Humana’s county-level pullback puts half a million seniors at risk
Humana has pointed to the payment environment described in the 2026 rate framework as the source of margin pressure driving its exit decisions. The rate announcement sets capitation benchmarks and payment policy changes that every Medicare Advantage insurer uses to decide where it can operate at a profit. When those benchmarks do not keep pace with medical costs in a given county, carriers face a choice: absorb losses, cut benefits, or leave.
Humana chose to leave. The result is that seniors in affected counties will need to act during the Annual Election Period this fall to enroll in a different Medicare Advantage plan or return to traditional Medicare with a standalone Part D drug plan. Those who do nothing could default into original Medicare without supplemental coverage, exposing them to out-of-pocket costs they did not budget for. For beneficiaries with chronic conditions or limited savings, even a short lapse in coordinated coverage can translate into delayed care, skipped medications, or unexpected medical debt.
Because Humana has framed the move as a response to inadequate reimbursement, a testable hypothesis follows from its strategy: the counties being dropped likely cluster around contracts with lower star ratings or higher medical-loss ratios, where the gap between what CMS pays and what Humana spends on claims is widest. If that pattern holds, Humana’s retained 2026 enrollment should show a measurably higher average risk-adjusted margin than its current book of business. That claim can be checked once CMS releases final enrollment files for the 2026 plan year, which report enrollment at the contract, plan, state, and county level.
For individual members, however, the financial logic behind Humana’s exit will matter far less than the practical steps required to maintain coverage. Beneficiaries will have to compare premiums, provider networks, drug formularies, and supplemental benefits across remaining plans, often with limited time and support. Those who have relied on Humana’s care management programs or particular in-network physicians may find that their preferred arrangements are no longer available at any price.
CMS data and Humana’s exit create competing pictures of stability
CMS has stated that Medicare Advantage and Medicare Prescription Drug Programs are expected to remain stable in 2026, with steady premiums and plan choices across the program. That framing reflects aggregate national trends: the total number of Medicare Advantage plans available, average premiums, and overall enrollment figures. At that altitude, a single carrier’s county exits can be absorbed by competitors backfilling the gap, and the market can still look healthy on paper.
On the ground, the picture looks different. In rural or less competitive counties where Humana may be one of only a few Medicare Advantage options, an exit can leave seniors with no comparable plan, or in some cases with only a single remaining carrier. CMS publishes service-area files by state and county, which allow independent verification of exactly where Humana offered plans in prior years and how many competitors operate in the same markets. Overlaying Humana’s 2025 footprint on those county-level data will show which communities face the sharpest contraction in choice when the company withdraws.
That tension-between national stability and local disruption-will shape how policymakers and regulators interpret Humana’s move. If other large insurers follow a similar playbook, concentrating on higher-margin counties while exiting more challenging ones, the Medicare Advantage program could remain numerically robust while becoming increasingly uneven. Urban beneficiaries might still see dozens of plan options, generous supplemental benefits, and aggressive marketing, while rural seniors confront thinner networks, higher cost sharing, or a forced return to original Medicare.
For now, the most immediate task lies with affected beneficiaries and the counselors, brokers, and community organizations that support them. As plan materials for 2026 are finalized, those groups will need to translate complex rate and policy changes into concrete guidance: which plans still include a person’s doctor, which drug tiers have shifted, and what total annual costs might look like under each option. Humana’s exit underscores that even in a “stable” market, seniors cannot assume their current plan will be there from one year to the next-and that the fine print of federal rate-setting can reverberate all the way down to a single county clinic.
